Author: OurCrowd

[Anthropic in Anthropic] Snowflake and Anthropic announce $200 million partnership to bring agentic AI to global enterprises

Dec 3, 2025 |

Today, we announce a significant expansion of our strategic partnership with Snowflake. The multi-year, $200 million agreement will not only make Anthropic’s Claude models available in the Snowflake platform to more than 12,600 global customers across Amazon Bedrock, Google Cloud Vertex AI, and Microsoft Azure, but also establishes a joint go-to-market (GTM) initiative focused on deploying AI agents across the world’s largest enterprises. Read...

Read More

[Blackshark.Ai in Lockheed Martin] Lockheed Martin, Blackshark.ai, debut next-gen image generator powered by unreal engine

Dec 2, 2025 |

ORLANDO, Fla., Dec. 2, 2025 – Today, Lockheed Martin [NYSE: LMT], with Blackshark.ai, unveiled Prepar3D® Fuse, a next‑generation simulation solution to prepare today’s soldier for any mission. Built on a custom version of Unreal Engine 5, Prepar3D® Fuse blends Lockheed Martin’s simulation legacy with commercially available cutting‑edge graphics and AI‑generated terrain and sensor‑modeling, giving warfighters, engineers and instructors a single environment for everything from initial flight training to joint, multi-domain exercises. Read more...

Read More

[Alpha Tau in Alpha Tau] Alpha Tau receives FDA Approval to initiate a trial for patients with locally recurrent prostate cancer

Dec 2, 2025 |

JERUSALEM, December 2, 2025 – Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for the treatment of patients with locally recurrent prostate cancer using the Company’s Alpha DaRT technology. Read...

Read More

[Eko Health in PR Newswire] CMS finalizes OPPS payment for Eko Health’s SENSORA® Platform, expanding reimbursement for AI-enabled cardiac disease detection in hospital-associated outpatient care

Dec 2, 2025 |

SAN FRANCISCO, Dec. 2, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary care, announced that the Centers for Medicare & Medicaid Services (CMS) has finalized national payment for its SENSORA® platform under the Outpatient Prospective Payment System (OPPS). The decision grants payment for SENSORA exams performed in outpatient settings, ensuring hospitals and health systems can receive reimbursement for AI-enabled cardiac detection delivered at the point of care. Read...

Read More